These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 15057784)
41. Abrogation of recurrent autoimmunity in the NOD mouse: A critical role for host interleukin 4. Shi Q; Wang D; Hadley GA; Farber DL; Bartlett ST Surgery; 2006 Aug; 140(2):281-8. PubMed ID: 16904981 [TBL] [Abstract][Full Text] [Related]
44. Parameters of the immune status in patients with newly diagnosed type 1 diabetes mellitus after islet cell transplantation. Dreval AV; Shishko PI; Skaletsky NN; Sadykova RE; Babicheva MG; Ignatenko NS; Efuni SS; Matukov AE; Polanskaya IS; Skuibin BG Transplant Proc; 1992 Dec; 24(6):3041-2. PubMed ID: 1466048 [No Abstract] [Full Text] [Related]
45. Role of chemokine signaling pathways in pancreatic islet rejection during allo- and xenotransplantation. Sigrist S; Ebel N; Langlois A; Bosco D; Toso C; Kleiss C; Mandes K; Berney T; Pinget M; Belcourt A; Kessler L Transplant Proc; 2005 Oct; 37(8):3516-8. PubMed ID: 16298647 [TBL] [Abstract][Full Text] [Related]
46. Deletion of STAT-1 pancreatic islets protects against streptozotocin-induced diabetes and early graft failure but not against late rejection. Callewaert HI; Gysemans CA; Ladrière L; D'Hertog W; Hagenbrock J; Overbergh L; Eizirik DL; Mathieu C Diabetes; 2007 Aug; 56(8):2169-73. PubMed ID: 17473223 [TBL] [Abstract][Full Text] [Related]
47. Beta-cell replacement therapy (pancreas and islet transplantation) for treatment of diabetes mellitus: an integrated approach. Sutherland DE; Gruessner R; Kandswamy R; Humar A; Hering B; Gruessner A Transplant Proc; 2004; 36(6):1697-9. PubMed ID: 15350456 [No Abstract] [Full Text] [Related]
48. Clinical islet cell transplantation. Are we there yet? Rosenberg L Int J Pancreatol; 1998 Dec; 24(3):145-68. PubMed ID: 9873950 [TBL] [Abstract][Full Text] [Related]
53. Factors influencing the loss of beta-cell mass in islet transplantation. Emamaullee JA; Shapiro AM Cell Transplant; 2007; 16(1):1-8. PubMed ID: 17436849 [TBL] [Abstract][Full Text] [Related]
55. Impact of donor immune cells in pancreatic islet transplantation. Carter JD; Chen M; Ellett JD; Smith KM; Nadler JL; Yang Z Transplant Proc; 2004 Nov; 36(9):2866-8. PubMed ID: 15621170 [TBL] [Abstract][Full Text] [Related]
56. [Islets of Langerhans or pancreas transplantation in the treatment of type 1 diabetes]. Baertschiger RM; Morel P; Berney T Rev Med Suisse; 2006 May; 2(68):1462-6. PubMed ID: 16783991 [TBL] [Abstract][Full Text] [Related]
57. Prolonged survival of fetal pig islet xenografts in mice lacking the capacity for an indirect response. Koulmanda M; Laufer TM; Auchincloss H; Smith RN Xenotransplantation; 2004 Nov; 11(6):525-30. PubMed ID: 15479462 [TBL] [Abstract][Full Text] [Related]
58. Diabetes. Islet transplants face test of time. Couzin J Science; 2004 Oct; 306(5693):34-7. PubMed ID: 15459359 [No Abstract] [Full Text] [Related]
59. New developments in pancreas and islet transplantation. Squifflet JP Transplant Proc; 2001; 33(7-8):3492-3. PubMed ID: 11750492 [No Abstract] [Full Text] [Related]